Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP410470.RA0Tgo59W_Q2qKrJT5mJq-6pEXE9-r3jV96oDz8vge5jU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP410470.RA0Tgo59W_Q2qKrJT5mJq-6pEXE9-r3jV96oDz8vge5jU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP410470.RA0Tgo59W_Q2qKrJT5mJq-6pEXE9-r3jV96oDz8vge5jU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP410470.RA0Tgo59W_Q2qKrJT5mJq-6pEXE9-r3jV96oDz8vge5jU130_provenance.
- NP410470.RA0Tgo59W_Q2qKrJT5mJq-6pEXE9-r3jV96oDz8vge5jU130_assertion description "[We also describe the recent development and validation of the most studied mucins (MUC1 and MUC16), ErbB-2 (Her2/neu) and folate binding protein as target-based immunotherapy of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410470.RA0Tgo59W_Q2qKrJT5mJq-6pEXE9-r3jV96oDz8vge5jU130_provenance.
- NP410470.RA0Tgo59W_Q2qKrJT5mJq-6pEXE9-r3jV96oDz8vge5jU130_assertion evidence source_evidence_literature NP410470.RA0Tgo59W_Q2qKrJT5mJq-6pEXE9-r3jV96oDz8vge5jU130_provenance.
- NP410470.RA0Tgo59W_Q2qKrJT5mJq-6pEXE9-r3jV96oDz8vge5jU130_assertion SIO_000772 14755889 NP410470.RA0Tgo59W_Q2qKrJT5mJq-6pEXE9-r3jV96oDz8vge5jU130_provenance.
- NP410470.RA0Tgo59W_Q2qKrJT5mJq-6pEXE9-r3jV96oDz8vge5jU130_assertion wasDerivedFrom befree-20150227 NP410470.RA0Tgo59W_Q2qKrJT5mJq-6pEXE9-r3jV96oDz8vge5jU130_provenance.
- NP410470.RA0Tgo59W_Q2qKrJT5mJq-6pEXE9-r3jV96oDz8vge5jU130_assertion wasGeneratedBy ECO_0000203 NP410470.RA0Tgo59W_Q2qKrJT5mJq-6pEXE9-r3jV96oDz8vge5jU130_provenance.
- befree-20150227 importedOn "2015-02-27" NP410470.RA0Tgo59W_Q2qKrJT5mJq-6pEXE9-r3jV96oDz8vge5jU130_provenance.